Published in PLoS One on July 10, 2014
Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc (2008) 62.52
Dendritic cells and the control of immunity. Nature (1998) 56.54
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol (2005) 30.22
A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (1997) 16.28
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science (2011) 15.79
Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol (2002) 14.75
The danger model: a renewed sense of self. Science (2002) 13.85
Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol (2012) 12.19
Taking dendritic cells into medicine. Nature (2007) 11.82
Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer. J Clin Oncol (2010) 9.86
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature (2004) 9.40
The regulation of IL-10 production by immune cells. Nat Rev Immunol (2010) 9.18
Decoding the patterns of self and nonself by the innate immune system. Science (2002) 7.19
Cancer immunotherapy via dendritic cells. Nat Rev Cancer (2012) 5.37
A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell (2005) 4.32
Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science (2002) 4.02
Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat Immunol (2001) 3.59
The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem (2001) 3.48
Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol (1998) 3.11
Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science (2001) 3.03
Dendritic-cell-based therapeutic cancer vaccines. Immunity (2013) 2.29
Interferon-gamma limits the availability of iron for intramacrophage Salmonella typhimurium. Eur J Immunol (2008) 2.25
Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J Exp Med (2000) 2.09
Lipocalin 2 promotes breast cancer progression. Proc Natl Acad Sci U S A (2009) 2.08
Identification of a new acute phase protein. J Biol Chem (1995) 1.96
The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett (2005) 1.96
A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production. Cell (2010) 1.85
Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. J Cell Biochem (2011) 1.52
Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes. J Clin Invest (2013) 1.32
DNA activates human immune cells through a CpG sequence-dependent manner. Immunology (1999) 1.23
LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells. J Leukoc Biol (2008) 1.23
Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells. Blood (2009) 1.21
Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis. Proc Natl Acad Sci U S A (2010) 1.19
Low-strength T-cell activation promotes Th17 responses. Blood (2010) 1.15
IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses. Vaccine (2006) 1.15
Bcr-Abl-mediated suppression of normal hematopoiesis in leukemia. Oncogene (2005) 1.13
Lipocalin 2 is required for BCR-ABL-induced tumorigenesis. Oncogene (2008) 1.11
Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur J Immunol (2000) 1.11
Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasis. J Immunol (2011) 1.09
High expression in involuting reproductive tissues of uterocalin/24p3, a lipocalin and acute phase protein. Biochem J (2002) 1.09
Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity. Immunol Invest (2012) 1.05
Effects of dexamethazone on LPS-induced activationand migration of mouse dendritic cells revealed by a genome-wide transcriptional analysis. Eur J Immunol (2006) 1.02
Central role of dendritic cells in the regulation and deregulation of immune responses. Cell Mol Life Sci (2008) 0.94
Generation of potent anti-tumor immunity in mice by interleukin-12-secreting dendritic cells. Cancer Immunol Immunother (2005) 0.93
Semi-mature IL-12 secreting dendritic cells present exogenous antigen to trigger cytolytic immune responses. Cancer Immunol Immunother (2005) 0.89
Immune tolerance induced by intravenous transfer of immature dendritic cells via up-regulating numbers of suppressive IL-10(+) IFN-γ(+)-producing CD4(+) T cells. Immunol Res (2013) 0.86
Identification of an indispensable role for tyrosine kinase 2 in CTL-mediated tumor surveillance. Cancer Res (2009) 0.85
IL-10 deficiency blocks the ability of LPS to regulate expression of tolerance-related molecules on dendritic cells. Eur J Immunol (2012) 0.84
Toll-like receptor 4 engagement drives differentiation of human and murine dendritic cells from a pro- into an anti-inflammatory mode. PLoS One (2013) 0.81
Lipocalin 2 performs contrasting, location-dependent roles in APCmin tumor initiation and progression. Oncogene (2012) 0.81
An optimized method for manufacturing a clinical scale dendritic cell-based vaccine for the treatment of glioblastoma. PLoS One (2012) 0.81
Dendritic cells as adjuvants in antitumor immune therapy. Onkologie (2002) 0.79
In vitro suppression of immune responses using monocyte-derived tolerogenic dendritic cells from patients with primary Sjögren's syndrome. Arthritis Res Ther (2013) 0.79
Effects of sublingual immunotherapy on allergic inflammation: an update. Inflamm Allergy Drug Targets (2012) 0.79